{
  "slug": "red-yeast-rice",
  "version": "1",
  "displayName": "Red yeast rice",
  "unit": "mg",
  "doseKind": "compound",
  "ingredientGroups": [
    "Red yeast rice"
  ],
  "shelfComparable": true,
  "primaryFloorId": "becker-2009",
  "trialFloors": [
    {
      "id": "becker-2009",
      "label": "Statin-intolerant RCT (Becker 2009)",
      "presetLabel": "Becker 2009",
      "amount": 3600,
      "frequency": "daily",
      "horizon": "24 weeks",
      "evidenceLevel": "limited",
      "pmids": [
        "19528562"
      ],
      "n": 62,
      "effectDirection": "benefit",
      "note": "1,800 mg twice per day (3,600 mg per day total) for 24 weeks in 62 adults with statin-intolerant dyslipidemia, randomized against placebo. LDL fell significantly. The effect is real because the active molecule is real: monacolin K is chemically identical to lovastatin, a statin-class drug effect delivered through a supplement label.",
      "funding": "independent"
    }
  ],
  "guideSlugs": [
    "berberine-vs-ozempic"
  ],
  "guideUrls": [
    "https://supplementbrief.com/berberine-vs-ozempic/"
  ],
  "shelf": {
    "registrySlug": "red-yeast-rice",
    "label": "Red yeast rice",
    "productCount": 554,
    "medianPerServing": 900,
    "p25PerServing": 600,
    "p75PerServing": 1200,
    "belowPrimaryFloorPct": 100,
    "abovePrimaryFloorPct": 0,
    "unit": "mg",
    "generatedAt": "2026-09-27T19:07:29.098Z",
    "source": "NIH DSLD bulk CSV (DietarySupplementFacts)"
  },
  "updatedDate": "2026-09-17",
  "dosePageUrl": "https://supplementbrief.com/dose/red-yeast-rice/",
  "jsonUrl": "https://supplementbrief.com/data/v1/doses/red-yeast-rice.json",
  "htmlUrl": "https://supplementbrief.com/data/v1/doses/red-yeast-rice/"
}
